BASILEA PHARMACEUTICA Trademark

Trademark Overview

On Tuesday, November 1, 2016, a trademark application was filed for BASILEA PHARMACEUTICA with the United States Patent and Trademark Office. The USPTO has given the BASILEA PHARMACEUTICA trademark a serial number of 87980984. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 16, 2026. This trademark is owned by Basilea Pharmaceutica International Ltd.. The BASILEA PHARMACEUTICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria
basilea pharmaceutica

General Information

Serial Number87980984
Word MarkBASILEA PHARMACEUTICA
Filing DateTuesday, November 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 16, 2026
Registration Number5795819
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

NOT AVAILABLE"PHARMACEUTICA"
Goods and ServicesPharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 16, 2026
Primary Code005
First Use Anywhere DateTuesday, April 9, 2019
First Use In Commerce DateTuesday, April 9, 2019

Trademark Owner History

Party NameBASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address4058 Basel
CH

Trademark Events

Event DateEvent Description
Friday, November 4, 2016NEW APPLICATION ENTERED
Friday, November 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 8, 2017ASSIGNED TO EXAMINER
Friday, February 10, 2017NON-FINAL ACTION WRITTEN
Friday, February 10, 2017NON-FINAL ACTION E-MAILED
Friday, February 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 9, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018SOU EXTENSION 1 FILED
Wednesday, May 9, 2018SOU EXTENSION 1 GRANTED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, October 31, 2018SOU EXTENSION 2 FILED
Wednesday, October 31, 2018SOU EXTENSION 2 GRANTED
Friday, November 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2019TEAS STATEMENT OF USE RECEIVED
Friday, May 3, 2019TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 3, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, May 21, 2019DIVISIONAL PROCESSING COMPLETE
Friday, May 3, 2019USE AMENDMENT FILED
Tuesday, May 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 28, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 29, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, June 28, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 16, 2026CANCELLED SEC. 8 (6-YR)

Related Keywords

pharmaceutica basilea infections caused bacteria prevention treatment products preparations pharmaceutical